ATE214381T1 - Thiazole derivate als protein kinase c inhibitoren - Google Patents

Thiazole derivate als protein kinase c inhibitoren

Info

Publication number
ATE214381T1
ATE214381T1 AT97933046T AT97933046T ATE214381T1 AT E214381 T1 ATE214381 T1 AT E214381T1 AT 97933046 T AT97933046 T AT 97933046T AT 97933046 T AT97933046 T AT 97933046T AT E214381 T1 ATE214381 T1 AT E214381T1
Authority
AT
Austria
Prior art keywords
inhibitors
protein kinase
thiazole derivatives
thiazole
derivatives
Prior art date
Application number
AT97933046T
Other languages
English (en)
Inventor
Toyoki Mori
Michiaki Tominaga
Fujio Tabusa
Kazuyoshi Nagami
Kaoru Abe
Kenji Nakaya
Isao Takemura
Tomoichi Shinohara
Yoshihisa Tanada
Takahito Yamauchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE214381T1 publication Critical patent/ATE214381T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97933046T 1996-07-31 1997-07-29 Thiazole derivate als protein kinase c inhibitoren ATE214381T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20089896 1996-07-31
PCT/JP1997/002609 WO1998004536A1 (en) 1996-07-31 1997-07-29 Thiazole derivative as protein kinase c inhibitors

Publications (1)

Publication Number Publication Date
ATE214381T1 true ATE214381T1 (de) 2002-03-15

Family

ID=16432095

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97933046T ATE214381T1 (de) 1996-07-31 1997-07-29 Thiazole derivate als protein kinase c inhibitoren

Country Status (16)

Country Link
US (1) US6140330A (de)
EP (1) EP0858452B1 (de)
KR (1) KR19990063910A (de)
CN (1) CN1070856C (de)
AR (1) AR008111A1 (de)
AT (1) ATE214381T1 (de)
AU (1) AU695817B2 (de)
BR (1) BR9706792A (de)
CA (1) CA2233611A1 (de)
DE (1) DE69711020T2 (de)
DK (1) DK0858452T3 (de)
ES (1) ES2179355T3 (de)
ID (1) ID19474A (de)
PT (1) PT858452E (de)
TW (1) TW513418B (de)
WO (1) WO1998004536A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849769A (en) * 1994-08-24 1998-12-15 Medivir Ab N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection
US6569878B1 (en) 1997-10-27 2003-05-27 Agouron Pharmaceuticals Inc. Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
IL135176A0 (en) 1997-11-10 2001-05-20 Bristol Myers Squibb Co Benzothiazole derivatives and pharmaceutical compositions containing the same
WO1999058514A1 (en) * 1998-05-12 1999-11-18 American Home Products Corporation (2-acylaminothiazole-4-yl)acetic acid derivatives
US6407124B1 (en) 1998-06-18 2002-06-18 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
CA2332325A1 (en) * 1998-06-18 1999-12-23 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
GB9823871D0 (en) 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
US6114365A (en) * 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
WO2001056567A1 (en) * 2000-02-04 2001-08-09 Novo Nordisk A/S 2,4-diaminothiazole derivatives and their use as glycogen synthase kinase-3 (gsk-3) inhibitors
JP2003521543A (ja) 2000-02-07 2003-07-15 アボット ゲーエムベーハー ウント カンパニー カーゲー 2−ベンゾチアゾリル尿素誘導体およびそのプロテインキナーゼ阻害剤としての使用
DE60212836T2 (de) * 2001-05-16 2007-01-25 Gpc Biotech Ag Pyridylpyrimidin-derivate als wirksame verbindungen gegen prionen-krankheiten
HN2002000156A (es) 2001-07-06 2003-11-27 Inc Agouron Pharmaceuticals Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
EP1724270A3 (de) 2001-07-19 2007-01-03 Pfizer Italia S.r.l. Phenylacetamido-thiazole Verbindungen, Verfahren zu ihren Herstellung und ihre Anwendung als antitumor Mittel
EP1505983A2 (de) * 2002-01-25 2005-02-16 Pharmacia Corporation Prävention und behandlung von durch entzündung bedingten krankheiten mit aldosteronhemmern
US7101898B2 (en) * 2002-02-01 2006-09-05 Novo Nordisk A/S Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
CN103130739B (zh) * 2003-08-12 2015-09-16 盐野义制药株式会社 具有血小板生成素受体激动作用的化合物
AU2005287729A1 (en) * 2004-09-22 2006-03-30 H. Lundbeck A/S 2-acylaminothiazole derivatives
US7674912B2 (en) * 2005-04-25 2010-03-09 H. Lundbeck A/S Pro-drugs of N-thiazol-2-yl-benzamide derivatives
TW200821316A (en) * 2006-07-19 2008-05-16 Astrazeneca Ab Novel compounds 243
WO2009011653A1 (en) * 2007-07-17 2009-01-22 Astrazeneca Ab A process for the preparation of intermediates and their us in the synthesis of spiropiperidine compounds
WO2009120826A1 (en) * 2008-03-27 2009-10-01 Wyeth 2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof
WO2011025951A1 (en) * 2009-08-28 2011-03-03 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
MX2012015105A (es) * 2010-07-02 2013-05-28 Gilead Sciences Inc Inhibidores de cinasa de regulacion mediante señal de apoptosis.
WO2012104857A1 (en) * 2011-02-04 2012-08-09 Council Of Scientific & Industrial Research Amidobenzothiazoles and process for the preparation thereof
ES2489297B1 (es) * 2013-01-22 2015-06-10 Consejo Superior De Investigaciones Científicas (Csic) Benzotiazoles sustituidos y sus aplicaciones terapeuticas para el tratamiento de enfermedades humanas
GB201401886D0 (en) 2014-02-04 2014-03-19 Lytix Biopharma As Neurodegenerative therapies
CN110317230B (zh) * 2018-03-30 2023-11-07 上海昇悦医药科技有限公司 磷酸盐类衍生物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001517A1 (en) * 1980-11-04 1982-05-13 Martin C Anderson Basic color media set for providing tonally matched palettes
US4957932A (en) * 1987-11-25 1990-09-18 Merck Frosst Canada, Inc. Benzoheterazoles
IL90337A0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
JP2869561B2 (ja) * 1989-05-22 1999-03-10 大塚製薬株式会社 血小板粘着抑制剤
TW205041B (de) * 1989-08-07 1993-05-01 Fujisawa Pharmaceutical Co
AU3884993A (en) * 1992-04-10 1993-11-18 Merck Frosst Canada Inc. Benzothiazole-substituted benzyl alcohols as leukotriene antagonists
AU3884893A (en) * 1992-04-10 1993-11-18 Merck Frosst Canada Inc. Thiazole-substituted benzyl alcohols as leukotriene antagonists
EP0638564B1 (de) * 1993-02-19 1999-09-01 Asahi Kasei Kogyo Kabushiki Kaisha Benzothiazolsulfonamid-derivate, verfahren zu deren herstellung und anwendungen

Also Published As

Publication number Publication date
DE69711020D1 (de) 2002-04-18
ES2179355T3 (es) 2003-01-16
BR9706792A (pt) 2001-11-27
EP0858452A1 (de) 1998-08-19
WO1998004536A1 (en) 1998-02-05
AU3635497A (en) 1998-02-20
CN1198160A (zh) 1998-11-04
ID19474A (id) 1998-07-16
AU695817B2 (en) 1998-08-20
HK1016586A1 (en) 1999-11-05
KR19990063910A (ko) 1999-07-26
DK0858452T3 (da) 2002-05-21
DE69711020T2 (de) 2002-11-21
AR008111A1 (es) 1999-12-09
US6140330A (en) 2000-10-31
TW513418B (en) 2002-12-11
CA2233611A1 (en) 1998-02-05
CN1070856C (zh) 2001-09-12
EP0858452B1 (de) 2002-03-13
PT858452E (pt) 2002-07-31

Similar Documents

Publication Publication Date Title
ATE214381T1 (de) Thiazole derivate als protein kinase c inhibitoren
ATE430149T1 (de) Heterocyclen substituierte imidazopyrazine als protein- tyrosin-kinase-inhibitoren
DE69627179D1 (de) Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren
ATE315394T1 (de) Benzothiazole als protein tyrosin-kinase inhibitoren
LTPA2014028I1 (lt) Pakeistieji 3-cianochinolinai kaip proteintirozinkinazės inhibitoriai
ATE251612T1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
ATE255575T1 (de) Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren
CY2008015I1 (el) Δικυκλικες ετepοαρωματικες ενωσεις σαν αναστολεις πρωτεϊνης κινασης τυροσινης
DK0912559T3 (da) Kondenserede heterocykliske forbindelser som proteintyrosinkinaseinhibitorer
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
DE69706292D1 (de) Chinazoline derivate
FI945706A7 (fi) Proteiinikinaasi C-inhibiittoreita
DE69720522D1 (de) Substituierte stickstoff enthaltende heterocyclen als p38 protein kinase inhibitoren
FI962800L (fi) Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
EP0891350A4 (de) Inhibioten der farnesylprotein-transferase
DE69511253D1 (de) Wasserlösliche 3-arylidene-2-oxindole derivate als tyrosine kinase inhibitoren
EP1165084A4 (de) Inhibitoren der prenyl-proteintransferasen
ATE233746T1 (de) Thiazole derivate
ATE205836T1 (de) Bicyclische 4-aralkylaminopyrimidin-derivate als tyrosinkinase-inhibitoren
EP0904080A4 (de) Inhibitoren der farnesyl-protein transferase
DE69730962D1 (de) Alkylaminobenzothiazole und -benzoxazole derivate
ATE387448T1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
DE69814894D1 (de) Isochinolin derivate als urokinase inhibitoren
DE69805974D1 (de) 5-aroylnaphthalin derivate
ATE273307T1 (de) Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee